Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Pharmacotherapy
|
May 1, 1986
Acute hepatotoxicity after excessively high doses of carbamazepine on two occasions
D R Luke, M L Rocci, D H Schaible, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1990
Validity of creatinine clearance estimates in the assessment of renal function
D R Luke, C E Halstenson, J A Opsahl, et al.
Circulatory Shock
|
July 1, 1991
Influence of pentoxifylline and related analogues in endotoxemic renal failure
K L Berens, J D Langston, K M Wasan, et al.
Clinical Chemistry
|
August 1, 1987
Improved liquid-chromatographic assay of labetalol in plasma
D R Luke, G R Matzke, J T Clarkson, et al.
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1986
Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the rat
D R Luke, M P O'Donnell, W F Keane, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1992
Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions
D R Luke, L J Brunner, G Lopez-Berestein, et al.
The Journal of Infectious Diseases
|
July 1, 1990
Enhancement of the treatment of experimental candidiasis with vascular decongestants
D R Luke, K M Wasan, T J McQueen, et al.
Journal of Clinical Pharmacology
|
March 1, 1995
Influence of human serum albumin content in formulations on the bioequivalency of interferon alfa-2a given by subcutaneous injection in healthy male volunteers
J Zhi, S B Teller, H Satoh, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1990
Pentoxifylline in amphotericin B toxicity rat model
K M Wasan, K Vadiei, G Lopez-Berestein, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
October 1, 1989
Cyclosporine pharmacokinetics and effect in the type I diabetic rat model
L J Brunner, L V Iyer, K Vadiei, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Pharmacotherapy
|
May 1, 1986
Acute hepatotoxicity after excessively high doses of carbamazepine on two occasions
D R Luke, M L Rocci, D H Schaible, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1990
Validity of creatinine clearance estimates in the assessment of renal function
D R Luke, C E Halstenson, J A Opsahl, et al.
Circulatory Shock
|
July 1, 1991
Influence of pentoxifylline and related analogues in endotoxemic renal failure
K L Berens, J D Langston, K M Wasan, et al.
Clinical Chemistry
|
August 1, 1987
Improved liquid-chromatographic assay of labetalol in plasma
D R Luke, G R Matzke, J T Clarkson, et al.
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1986
Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the rat
D R Luke, M P O'Donnell, W F Keane, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1992
Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions
D R Luke, L J Brunner, G Lopez-Berestein, et al.
The Journal of Infectious Diseases
|
July 1, 1990
Enhancement of the treatment of experimental candidiasis with vascular decongestants
D R Luke, K M Wasan, T J McQueen, et al.
Journal of Clinical Pharmacology
|
March 1, 1995
Influence of human serum albumin content in formulations on the bioequivalency of interferon alfa-2a given by subcutaneous injection in healthy male volunteers
J Zhi, S B Teller, H Satoh, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1990
Pentoxifylline in amphotericin B toxicity rat model
K M Wasan, K Vadiei, G Lopez-Berestein, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
October 1, 1989
Cyclosporine pharmacokinetics and effect in the type I diabetic rat model
L J Brunner, L V Iyer, K Vadiei, et al.
Page
of 7